Amit Bakshi

Eris Lifesciences Limited Q3FY22 Revenues at INR 3,322 mn, up 7.0% YoY

EBITDA at INR 1,217 mn, up 13.5% YoY PAT stood at INR 1,008 mn, up 11.8% YoY Mumbai, January 29,…

3 years ago

Eris Lifesciences extends its focus on disease prevention with the launch of ‘TruSaniz’ hand sanitizer

ropes in wellness entrepreneur, Shilpa Shetty Kundra as its brand ambassador Mumbai, May 27, 2020: Eris Lifesciences (BSE: 540596; NSE:…

4 years ago

World’s First Smart Continuous Glucose Monitoring System now in India

Eris Lifesciences joins hands with Medtronicto bring Guardian Connect to India Mumbai, January 04, 2019 : Guardian Connect is the world’s first…

6 years ago

Diabetes major Eris Lifesciences joins hands with Medtronic for diabetes monitoring initiative

Mumbai, January 04, 2018: In a first of its kind collaborative initiative in India between a pharmaceutical and medical device company,…

6 years ago